Thiazolidinediones, including rosiglitazone, cause or exacerbate congestive heart failure in some patients.
Contra-indicated in patients with established NYHA Class III or IV heart failure.
Avandaryl is rosiglitazone and glimepiride; Avandamet is rosiglitazone and metformin.